Product News
Filter News
Found 181,565 articles
-
Shares of Verastem closed out Monday trading on a positive note and continues to climb in the premarket following the greenlight for leukemia drug Copiktra, an inhibitor of phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma.
-
A commercially-available medical device developed by Medtronic is helping paralyzed patients walk again.The device, which stimulates the spinal cord through electrical pulses, has been successful in helping some individuals who lost the ability to walk through injuries to their spine, regain the ...
-
Tesaro Highlights Benefits of Maintenance Therapy Zejula During Ovarian Cancer Awareness Month
9/25/2018
Ovarian cancer is the fifth leading cause of cancer-related deaths in the United States. It is estimated that this year there will be more than 22,000 women in the U.S. diagnosed with the disease and about 14,000 disease-related deaths. -
TrialScope Unveils New Clinical Trial Transparency and Health Literacy Service for Sponsors
9/25/2018
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the launch of its Clinical Trial Transparency Service (CTTS). This transparency and health literacy management solution enables clinical trial sponsors to engage with patients, healthcare professionals, researchers and the public via a dedicated clinical trial informational website.
-
NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate
9/25/2018
Data in Diverse Patient Populations from Three Continents Presented at World Congress of Endourology 2018 Annual Conference
-
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
9/25/2018
WIPO and the research-based pharmaceutical industry today launched a new online tool designed to help procurement agencies better understand the global patent status of medicines.
-
FDA Grants QIDP and Fast Track Designations to Cidara Therapeutics’ Rezafungin Prophylaxis Development Program
9/25/2018
Cidara Therapeutics Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations for the company’s prophylaxis (prevention) development program for lead antifungal product candidate, rezafungin for injection.
-
Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society
9/25/2018
Intec Pharma Ltd. today announces that three posters in support of the Company's Phase 3 clinical development program for the Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD), will be presented at the upcoming International Congress of Parkinson's and Movement Disorder Society (MDS 2018) being held from October 5-9, 2018 in Hong Kong.
-
Gluten-Free New England: Region's Sizzling New Resource
9/25/2018
Gluten-Free New England, LLC is delighted to present the region's premier resource for healthy gluten-free living. Their just-launched website offers a dining directory, events calendar, reviews, recipes, and articles contributed by local writers and experts. They also organize large-scale expos, festivals, and farm dinners, and provide outreach for teens and young families.
-
The Arbor Company Publishes Comprehensive Resource for Families Considering Senior Living
9/25/2018
New Guide Details Every Step of the Journey, Including Choosing a Community and Moving In
-
FSD Pharma Receives First Delivery of Cantabb Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day
9/25/2018
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab Therapeutics Limited (CSE:PILL) ("Canntab"), a leader in the rapidly growing cannabis pill market
-
GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals
9/25/2018
The new license provides access to the largest growing sectors in the cannabis industry. Multiple new brands for both medical and recreational markets being prepped for retail sales.
-
Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers
9/25/2018
Applied DNA Sciences Inc. announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution.
-
Heathrow Scientific Introduces the MagFuge®, a First-of-its-Kind High-speed Centrifuge and Magnetic Stirrer in One Unit, to its Laboratory Equipment Line
9/25/2018
Heathrow Scientific, a leader in manufacturing bench top equipment and lab essentials for scientific and clinical markets announces the introduction of the MagFuge®, a first-of-its-kind high-speed centrifuge and magnetic stirrer in one unit.
-
New American Cancer Society Cookbook Offers More Than 130 Recipes to Help Patients Cope with Nutrition Challenges While Undergoing Treatment
9/25/2018
The American Cancer Society will release the second edition of What to Eat During Cancer Treatment on Oct. 1.
-
Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease
9/25/2018
Cerevance today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson’s disease.
-
APA Announces Employers For 2018 Psychologically Healthy Workplace Honors
9/25/2018
Nearly two dozen workplaces recognized for fostering employee well-being, organizational performance
-
FirstLight Home Care Coming to Tampa Bay Area
9/25/2018
National non-medical home care provider announces two new locations serving both Hillsborough and Pasco counties
-
Celsius Obtains Placements In Healthy Vending
9/25/2018
Celsius Holdings, Inc. (Nasdaq: CELH), maker of the clinically proven, globally marketed, functional, healthy energy CELSIUS® drinks, today announces that CELSIUS® Originals have been added to vending machines and micro-markets of refreshment solution providers including Accent Foods, Canteen, First Class Vending, Five Star Food Service and Southern Refreshment.
-
AstraZeneca Ships FLUMIST® QUADRIVALENT Vaccine in the US for 2018-2019 Flu Season
9/25/2018
Appropriate patients can receive the only needle-free, nasal spray flu vaccine from physicians as soon as late September